Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;87(3):191-193.
doi: 10.1016/j.jbspin.2020.03.011.

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Luca Quartuccio  1 , Luca Semerano  2 , Maurizio Benucci  3 , Marie-Christophe Boissier  2 , Salvatore De Vita  4
Affiliations
Editorial

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Luca Quartuccio et al. Joint Bone Spine. 2020 May.
No abstract available

Keywords: COVID-19; Coronavirus; Cytokine; IL-6; SARS.

PubMed Disclaimer

Comment in

References

    1. Lai C.C., Wang C.Y., Wang Y.H., et al. Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020:105946. doi: 10.1016/j.ijantimicag.2020.105946. - DOI - PMC - PubMed
    1. Yuen K.S., Ye Z.W., Fung S.Y., et al. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10:40. - PMC - PubMed
    1. Zhou D., Dai S.M., Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 doi: 10.1093/jac/dkaa114. - DOI - PMC - PubMed
    1. Conti P., Ronconi G., Caraffa A., et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 doi: 10.23812/CONTI-E. - DOI - PubMed
    1. De Vita S., Quartuccio L., Isola M., et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:843–853. - PubMed

Publication types

MeSH terms